Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 8.13% is 229% above its 5-year average of 2.47%, near the high end of its 5-year range (-1.91%–9.73%).
52.82% above its 12-month average of 5.32%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
8.13%
RETURN ON ASSETS (ROA) AVG TTM
5.32%
RETURN ON ASSETS (ROA) AVG 3Y
4.08%
RETURN ON ASSETS (ROA) AVG 5Y
2.47%
RETURN ON ASSETS (ROA) AVG 10Y
2.74%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+52.82%
CURRENT VS 3Y AVG
+99.14%
CURRENT VS 5Y AVG
+228.71%
CURRENT VS 10Y AVG
+197.21%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.41%
median of 85 covered companies
CURRENT VS SECTOR MEDIAN
+50.28%
vs the sector median at left
Penumbra, Inc.
Market Cap
$12.64B
Return on Assets (ROA)
8.13%
TTM Avg
5.32%
3Y Avg
4.08%
5Y Avg
2.47%
Market Cap
$12.38B
Return on Assets (ROA)
-10.75%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$13.41B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$11.86B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$13.84B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$13.89B
Return on Assets (ROA)
34.50%
TTM Avg
22.59%
3Y Avg
17.42%
5Y Avg
13.40%
Market Cap
$11.38B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$11.35B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Penumbra, Inc. (PEN) | $12.64B | 8.13% | 5.32% | 4.08% | 2.47% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | -10.75% | -43.49% | -42.71% | -41.26% |
| Baxter International Inc. (BAX)vs › | $13.41B | -5.37% | -3.64% | -1.62% | 0.47% |
| Encompass Health Corporation (EHC)vs › | $11.86B | 8.33% | 7.48% | 6.38% | 5.99% |
| DaVita Inc. (DVA)vs › | $11.48B | 4.79% | 4.84% | 4.27% | 4.56% |
| The Cooper Companies, Inc. (COO)vs › | $13.84B | 1.89% | 3.10% | 3.02% | 7.71% |
| Exelixis, Inc. (EXEL)vs › | $13.89B | 34.50% | 22.59% | 17.42% | 13.40% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 6.44% | 6.68% | 6.69% | 12.75% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 7.03% | 4.83% | 6.67% | 7.46% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 9.76% | 6.05% | 5.92% | 6.23% |
ROA
8.1%
ROE
10.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 9.73% |
| 2024-12-31 | 0.91% |
| 2023-12-31 | 5.84% |
| 2022-12-31 | -0.15% |
| 2021-12-31 | 0.42% |
| 2020-12-31 | -1.91% |
| 2019-12-31 | 7.28% |
| 2018-12-31 | 1.28% |
| 2017-12-31 | 0.98% |
| 2016-12-31 | 4.81% |
| 2015-12-31 | 0.90% |
| 2014-12-31 | 1.85% |
| 2013-12-31 | 5.76% |
| 2012-12-31 | 0.00% |
